迈普医学：“可吸收再生氧化纤维素止血颗粒”于近期进入临床试验阶段

Core Viewpoint - The company Maipu Medical has announced that its research project "Absorbable Regenerative Oxidized Cellulose Hemostatic Granules" has officially entered the clinical trial phase [1] Clinical Application - The product is intended for use in surgical procedures where traditional hemostatic methods, such as ligation, are not feasible or ineffective, serving as an auxiliary hemostatic product to control bleeding from capillaries, veins, and small arteries [1]